Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makishima

Showing results (711-720 of 737) with videos related to

Pageof 74
Sort By:
Nature Genetics|July 9, 2013
Somatic SETBP1 mutations in myeloid malignanciesHideki Makishima, Kenichi Yoshida, Nhu Nguyen, et al.
BMJ Open|June 2, 2026
Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocolKeisuke Koroki, Masaru Wakatsuki, Sadahisa Ogasawara, et al.
The Journal of Clinical Investigation|August 1, 2017
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transitionFrancis O Enane, Wai Ho Shuen, Xiaorong Gu, et al.
Experimental Hematology|April 16, 2016
GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndromeLacramioara Botezatu, Lars C Michel, Hideki Makishima, et al.
Blood|February 23, 2017
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantationTetsuichi Yoshizato, Yasuhito Nannya, Yoshiko Atsuta, et al.
Blood Advances|October 23, 2020
Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemiaHiroo Ueno, Kenichi Yoshida, Yusuke Shiozawa, et al.
Nature Communications|May 15, 2021
Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemiaYotaro Ochi, Kenichi Yoshida, Ying-Jung Huang, et al.
Nature Medicine|December 9, 2014
Mutations in G protein β subunits promote transformation and kinase inhibitor resistanceAkinori Yoda, Guillaume Adelmant, Jerome Tamburini, et al.
Leukemia|January 27, 2019
Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomasKeisuke Kataoka, Hiroaki Miyoshi, Seiji Sakata, et al.
Haematologica|May 24, 2015
BRCC3 mutations in myeloid neoplasmsDayong Huang, Yasunobu Nagata, Vera Grossmann, et al.
Pageof 74

Showing results (711-720 of 737) with videos related to

Sort By:
Pageof 74
Nature Genetics|July 9, 2013
Somatic SETBP1 mutations in myeloid malignanciesHideki Makishima, Kenichi Yoshida, Nhu Nguyen, et al.
BMJ Open|June 2, 2026
Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocolKeisuke Koroki, Masaru Wakatsuki, Sadahisa Ogasawara, et al.
The Journal of Clinical Investigation|August 1, 2017
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transitionFrancis O Enane, Wai Ho Shuen, Xiaorong Gu, et al.
Experimental Hematology|April 16, 2016
GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndromeLacramioara Botezatu, Lars C Michel, Hideki Makishima, et al.
Blood|February 23, 2017
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantationTetsuichi Yoshizato, Yasuhito Nannya, Yoshiko Atsuta, et al.
Blood Advances|October 23, 2020
Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemiaHiroo Ueno, Kenichi Yoshida, Yusuke Shiozawa, et al.
Nature Communications|May 15, 2021
Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemiaYotaro Ochi, Kenichi Yoshida, Ying-Jung Huang, et al.
Nature Medicine|December 9, 2014
Mutations in G protein β subunits promote transformation and kinase inhibitor resistanceAkinori Yoda, Guillaume Adelmant, Jerome Tamburini, et al.
Leukemia|January 27, 2019
Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomasKeisuke Kataoka, Hiroaki Miyoshi, Seiji Sakata, et al.
Haematologica|May 24, 2015
BRCC3 mutations in myeloid neoplasmsDayong Huang, Yasunobu Nagata, Vera Grossmann, et al.
Pageof 74